Could multiple sclerosis cut dementia risk?

Recent research has shown that people living with multiple sclerosis (MS) are much less likely to display the molecular markers associated with Alzheimer’s disease. This finding suggests that there might be a protective factor within MS that could pave the way for new treatments for Alzheimer’s.

The study discovered that those with MS had 50% less amyloid plaque build-up – a key sign of Alzheimer’s – compared to individuals without MS. This link between MS and a lower risk of Alzheimer’s points to potential immune-related mechanisms that could be explored for future therapies.

MS can cause cognitive impairment which can sometimes be confused with symptom’s of Alzheimer’s disease, however the latter can be confirmed with biological tests.